Green Biologics operates within a range of industry certifications, including United States Department of Agriculture (USDA) certification under the “BioPreferred” program. This certification enables our customers to display the “USDA Certified Bio-based Product” label for certain formulations. Our products are third-party tested, and the bio-based content is independently verified. The USDA label makes it easy for consumers to locate and compare bio-based products for purchase. By choosing a bio-based product certified by USDA, consumers are assured that the United States federal government stands behind the accuracy of the percent of bio-based ingredients as stated on the label. The label also gives products preferred status for government procurement in a range of categories such as paints, coatings, inks, and more. At Green Biologics, our products are currently certified as 100% bio-based. To learn more about the BioPreferred program, go to https://www.biopreferred.gov/BioPreferred/
The Responsible Care program also audits Green Biologics as part of their global program. Responsible Care is a voluntary initiative developed autonomously by the chemical industry for the chemical industry. This program seeks to improve the industry’s environmental, health, safety, and security performance. It runs in 67 countries whose combined chemical industries account for nearly 90% of global chemical production. In fact, 96 of the 100 largest chemical producers in the world have adopted the Responsible Care program.
Green Biologics complies with The Nagoya Protocol, an international agreement developed to create fair and equitable benefit sharing when accessing genetic resources. To implement the Nagoya Protocol, we comply with the requirements of Regulation (EU) No. 511/2014, which was made part of English law through the Nagoya Protocol in 2015. One of the key principles of the protocol is that anyone wishing to access genetic resources from another country must demonstrate comprehensive due diligence.
In 2016, a cradle-to-gate greenhouse gas assessment was carried out by independent consultant North Energy Associates (Northumberland, UK) to the UK standard PAS2050:2011. The study covered the production of bio n-butanol from corn at the Green Biologics’ production facility in Minnesota. The methodology used in this report takes into consideration the carbon contained in petrochemical butanol as fossil derived and the carbon produced during our production process as biogenic. This translates into greenhouse gas savings for bio-butanol of 44 percent compared to petrochemical butanol.
The study was completed in 2016, before the construction of the Green Biologics plant was complete and prior to its start-up. As the company continues to improve performance, increase production rates, and improve efficiency, we expect to achieve further greenhouse gas reductions. We expect to achieve further greenhouse gas reductions and have commissioned a new impact assessment based on current data that should be completed in the third quarter of 2019.